BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 16242000)

  • 21. [A new strategy for treating small cell lung cancer].
    Ueda R; Takashi T
    Nihon Kyobu Shikkan Gakkai Zasshi; 1996 Dec; 34 Suppl():111-4. PubMed ID: 9216197
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Applications of tissue microarray technology in immunohistochemistry: a study on c-kit expression in small cell lung cancer.
    Donati V; Faviana P; Dell'omodarme M; Prati MC; Camacci T; De Ieso K; Giannini R; Lucchi M; Mussi A; Pingitore R; Basolo F; Fontanini G
    Hum Pathol; 2004 Nov; 35(11):1347-52. PubMed ID: 15668891
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Activating mutations in receptor tyrosine kinases with relevance for treatment of gastrointestinal stromal tumors].
    Wardelmann E; Merkelbach-Bruse S; Büttner R; Schildhaus HU
    Verh Dtsch Ges Pathol; 2007; 91():165-8. PubMed ID: 18314611
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Kit expression in spindle cell rhabdomyosarcoma can possibly create a different approach for its tumorigenesis and therapy.
    Diniz G; Aktas S; Ortac R; Tunakan M; Unlu I; Vergin C
    Pathol Res Pract; 2006; 202(9):671-7. PubMed ID: 16860492
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An immunohistochemical and molecular study of gastrointestinal stromal tumours.
    Teong YT; Teo ST; Tan LP; Wu BQ; Peh SC
    Med J Malaysia; 2006 Dec; 61(5):526-33. PubMed ID: 17623951
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Protein expression of KIT and gene mutation of c-kit and PDGFRs in Ewing sarcomas.
    Do I; Araujo ES; Kalil RK; Bacchini P; Bertoni F; Unni KK; Park YK
    Pathol Res Pract; 2007; 203(3):127-34. PubMed ID: 17298867
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunohistochemical and genetic analysis of Chinese nasal natural killer/T-cell lymphomas.
    Li T; Zhang B; Ye Y; Yin H
    Hum Pathol; 2006 Jan; 37(1):54-60. PubMed ID: 16360416
    [TBL] [Abstract][Full Text] [Related]  

  • 28. KIT immunohistochemistry and mutation status in gastrointestinal stromal tumours (GISTs) evaluated for treatment with imatinib.
    Loughrey MB; Trivett M; Beshay V; Dobrovic A; Kovalenko S; Murray W; Lade S; Turner H; McArthur GA; Zalcberg J; Waring PM
    Histopathology; 2006 Jul; 49(1):52-65. PubMed ID: 16842246
    [TBL] [Abstract][Full Text] [Related]  

  • 29. High-resolution melting amplicon analysis as a method to detect c-kit and platelet-derived growth factor receptor alpha activating mutations in gastrointestinal stromal tumors.
    Holden JA; Willmore-Payne C; Coppola D; Garrett CR; Layfield LJ
    Am J Clin Pathol; 2007 Aug; 128(2):230-8. PubMed ID: 17638656
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gastro-intestinal stromal tumour--role of CD117 in diagnosis and management.
    Paul PC; Chakraborty J; Kundu D; Sarkar R
    Indian J Pathol Microbiol; 2007 Apr; 50(2):279-83. PubMed ID: 17883045
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical implications of C-kit gene mutation in patients with large gastrointestinal stromal tumors.
    Lin SC; Liu CL; Wang TI; Chang WS; Tzen CY; Huang MJ
    J Gastroenterol Hepatol; 2006 Oct; 21(10):1604-8. PubMed ID: 16928224
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Evidence on the carcinogenicity of silica at DNA level in human].
    Liu B; Guan R; Zhou P; Miao Q
    Wei Sheng Yan Jiu; 1999 Sep; 28(5):257-8. PubMed ID: 12712688
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Familial gastrointestinal stromal tumors caused by the novel KIT exon 17 germline mutation N822Y.
    Thalheimer A; Schlemmer M; Bueter M; Merkelbach-Bruse S; Schildhaus HU; Buettner R; Hartung E; Thiede A; Meyer D; Fein M; Maroske J; Wardelmann E
    Am J Surg Pathol; 2008 Oct; 32(10):1560-5. PubMed ID: 18724244
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Analysis of KIT (CD117) expression in gallbladder carcinomas by tissue microarray.
    Langner C; Lemmerer M; Kornprat P
    Eur J Surg Oncol; 2004 Oct; 30(8):847-50. PubMed ID: 15336730
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [c-Kit and PDGFRA mutations and clinico-morphological features of gastrointestinal stromal tumors].
    Beliakov IS; Anurova OA; Snigur PV; Tsyganova IV; Sel'chuk VIu; Mazurenko NN
    Vopr Onkol; 2007; 53(6):677-81. PubMed ID: 18416137
    [TBL] [Abstract][Full Text] [Related]  

  • 36. KIT-positive primary small cell carcinoma of the endometrium: a case report with immunohistochemical and molecular genetic analysis of KIT and PDGFRA genes.
    Terada T
    Arch Gynecol Obstet; 2010 Oct; 282(4):413-6. PubMed ID: 20035340
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparative validation of c-kit exon 11 mutation analysis on cytology samples and corresponding surgical resections of gastrointestinal stromal tumours.
    Pang NK; Chin SY; Nga ME; Chang AR; Ismail TM; Omar SS; Charlton A; Salto-Tellez M
    Cytopathology; 2009 Oct; 20(5):297-303. PubMed ID: 19207305
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression and mutation analysis of the tyrosine kinase c-kit in poorly differentiated and anaplastic thyroid carcinoma.
    Broecker-Preuss M; Sheu SY; Worm K; Feldkamp J; Witte J; Scherbaum WA; Mann K; Schmid KW; Schott M
    Horm Metab Res; 2008 Oct; 40(10):685-91. PubMed ID: 18622894
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CD117 (c-kit) expression in human hepatocellular carcinoma.
    Becker G; Schmitt-Graeff A; Ertelt V; Blum HE; Allgaier HP
    Clin Oncol (R Coll Radiol); 2007 Apr; 19(3):204-8. PubMed ID: 17359908
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Absence of gene mutations in KIT-positive thymic epithelial tumors.
    Tsuchida M; Umezu H; Hashimoto T; Shinohara H; Koike T; Hosaka Y; Eimoto T; Hayashi JI
    Lung Cancer; 2008 Dec; 62(3):321-5. PubMed ID: 18486988
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.